Form 4 for MNKD MANNKIND CORP
Accepted 2022-08-23 00:00:00 ET · period of report 2022-08-22 · accession 0001209191-22-047280 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-23 | 2022-08-22 | MNKD | Galindo Alejandro | EVP Endocrine Business Unit | S - Sale | $3.85 | -4,615 | 777.1K | -0.6% | -$17.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 Par Value | 2022-08-22 | S | D | 4,600 | $3.85 | 777,090 | D | — | — | |
| 2 | Common | Common Stock, $0.01 Par Value | 2022-08-22 | S | D | 15 | $3.84 | 777,075 | D | — | — |